The Relation Therapeutics team (L-R): CSO Edith Hessel, COO Benjamin Swerner, SVP, growth and operations Rosie Rodriguez, CTO Lindsay Edwards and CEO David Roblin

Ex­clu­sive: ‘Chat­G­PT for DNA’: Re­la­tion nabs $35M, with Nvidia back­ing, for os­teo­poro­sis work

The ven­ture arm of Nvidia, the su­per­com­put­ing gi­ant ris­ing up the world’s most valu­able com­pa­nies chart, is back­ing a com­pu­ta­tion­al drug dis­cov­ery start­up that’s head­ed to­ward the clin­ic for os­teo­poro­sis, a large field with few in­no­va­tions.

Re­la­tion Ther­a­peu­tics has added $35 mil­lion to its cof­fers, the com­pa­ny ex­clu­sive­ly told End­points News. Nvidia’s NVen­tures, DCVC, Deer­field Man­age­ment Com­pa­ny, Khosla Ven­tures, Ab­cam founder Jonathan Mil­ner, ARK In­vest and Mag­net­ic Ven­tures con­tributed funds, which bring the to­tal seed fi­nanc­ing to $60 mil­lion.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.